Funding Support

FUNDING FOR THE OMEGA-6 FATTY ACIDS PROJECTS

Consortium projects on omega-6 fatty acids in relation to cardiovascular disease and diabetes were mainly funded by local grants, whereas some cohorts received partial funding provided by a unrestricted grant from UNILEVER. Other projects of the collaborative group have been partially unfunded.

COHORT FUNDING

ARIC

ARIC was supported by the NHLBI (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C)

CHS

CHS was supported by contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grant U01HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). 

The Costa-Rican Adults study was supported by grant R01HL081549 

EURAMIC was supported by the Commission of the European Communities, as a Concerted Action within Directorate General-XII, with additional support from Directorate General-V Europe Against Cancer. The national studies were financed by the Dutch Ministry of Health; Ulster Cancer Foundation and Milk Intervention Board; grant AKT76 from Cancer Research Switzerland; Swiss National Science Foundation Grant 32-9257-87; Spanish FIS & Ministry of Science and Education, and German Federal Health Office.

EPIC

EPIC-Norfolk was funded by grants from Medical Research Council and Cancer Research UK. Dr. Imamura also received support from the Medical Research Council Epidemiology Unit Core Support (MC_UU_12015/5)

FHS

FHS was supported by N01-HC-25195

HPFS was supported by the NIH grants AA11181, HL35464, CA55075, HL60712 and P30 DK46200

The InChianti study was supported as a ‘targeted project’ (ICS 110.1\RS97.71) by the Italian Ministry of Health and in part by the Intramural Research Program of the NIH (Contracts N01-AG-916413 and N01-AG-821336 and Contracts 263 MD 9164 13 and 263 MD 821336)

KIND was supported by grants from the Academy of Finland, Helsinki, Finland (grants 41471, 1041086)

MCCS (Melbourne Collaborative Cohort Study) was funded by VicHealth and Cancer Council Victoria

MESA

MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and CTSA UL1-RR-024156

NSHDS I & II was supported by the Swedish Cancer Society and the Swedish Research Council

NHS

NHS I was supported by research grants P01CA87969, R01HL034594, and R01HL088521 of the National Institutes of Health

PHS was supported by grant R21 HL088081, from the NHLBI, Bethesda, MD. The Physicians’ Health Study is supported by grants CA-34944 and CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the NHLBI 

The 3C study was conducted under a partnership agreement between the Institut National de la Santé et de la Recherche Médicale (INSERM), the University Bordeaux 2 Victor Segalen and Sanofi-Aventis. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The Three-City study was also supported by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Conseils Régionaux d’Aquitaine et Bourgogne, Fondation de France, Ministry of Research-INSERM Programme “Cohortes et collections de données biologiques”,  Agence Nationale de la Recherche (grant number COGINUT ANR-06-PNRA-005), the Fondation Plan Alzheimer (grant number FCS 2009-2012), and the Caisse Nationale pour la Solidarité et l’Autonomie (CNSA) . Dr Samieri was on a grant from the “Fondation Plan Alzheimer”

SHHECS was funded by the Scottish Health Department Chief Scientist Organization; British Heart Foundation; FP Fleming Trust

SCHS was supported by the Singapore National Medical Research Council (grant number: NMRC 1270/2010) and the U.S. NIH (grant numbers: R01CA 144034 and UM1 CA182876)

UPPSALA

ULSAM 50 and 70 were funded by the Swedish Research Council for Health, Working Life and Welfare (FORTE) Uppsala City Council (ALF) and Swedish Research Council